Zurich Cantonal Bank’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $377K | Buy |
26,968
+8,304
| +44% | +$116K | ﹤0.01% | 1834 |
|
|
2025
Q1 | $252K | Hold |
18,664
| – | – | ﹤0.01% | 1973 |
|
|
2024
Q4 | $358K | Buy |
18,664
+4,667
| +33% | +$89.5K | ﹤0.01% | 1830 |
|
|
2024
Q3 | $318K | Buy |
13,997
+2,036
| +17% | +$46.3K | ﹤0.01% | 1842 |
|
|
2024
Q2 | $156K | Buy |
11,961
+2,359
| +25% | +$30.7K | ﹤0.01% | 2160 |
|
|
2024
Q1 | $168K | Buy |
9,602
+1,233
| +15% | +$21.6K | ﹤0.01% | 2140 |
|
|
2023
Q4 | $182K | Buy |
8,369
+4,610
| +123% | +$100K | ﹤0.01% | 2137 |
|
|
2023
Q3 | $57.7K | Hold |
3,759
| – | – | ﹤0.01% | 2565 |
|
|
2023
Q2 | $89.4K | Hold |
3,759
| – | – | ﹤0.01% | 2396 |
|
|
2023
Q1 | $95.6K | Hold |
3,759
| – | – | ﹤0.01% | 2301 |
|
|
2022
Q4 | $110K | Hold |
3,759
| – | – | ﹤0.01% | 2211 |
|
|
2022
Q3 | $77K | Buy |
+3,759
| New | +$77K | ﹤0.01% | 2403 |
|